siPRDX2-elevated DNM3 inhibits the proliferation and metastasis of colon cancer cells via AKT signaling pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Maeda H, Kashiwabara K, Aoyama T, et al. Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese foundation for multi-disciplinary treatment of cancer (JFMC) clinical trials. J Cancer. 2017;8(19):4057–4064. doi:10.7150/jca.2136529187881
   PubMed Web of Science ®Google Scholar
• Veenstra CM, Krauss JC. Emerging systemic therapies for colorectal cancer. Clin Colon Rectal Surg. 2018;31(3):179–191. doi:10.1055/s-0037-160223829720904
   PubMed Web of Science ®Google Scholar
• Vecchione L, Gambino V, Raaijmakers J, et al. A vulnerability of a subset of colon cancers with potential clinical utility. Cell. 2016;165(2):317–330. doi:10.1016/j.cell.2016.02.05927058664
   PubMed Web of Science ®Google Scholar
• Yu F, Zhou C, Zeng H, Liu Y, Li S. BMI1 activates WNT signaling in colon cancer by negatively regulating the WNT antagonist IDAX. Biochem Biophys Res Commun. 2018;496(2):468–474. doi:10.1016/j.bbrc.2018.01.06329337063
   PubMed Web of Science ®Google Scholar
• Brown JD, Day AM, Taylor SR, Tomalin LE, Morgan BA, Veal EA. A peroxiredoxin promotes H2O2 signaling and oxidative stress resistance by oxidizing a thioredoxin family protein. Cell Rep. 2013;5(5):1425–1435. doi:10.1016/j.celrep.2013.10.03624268782
   PubMed Web of Science ®Google Scholar
• Kim K, Yu M, Han S, et al. Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis. Oncol Rep. 2009;21(6):1391–1396. 19424615
   PubMed Web of Science ®Google Scholar
• Stresing V, Baltziskueta E, Rubio N, et al. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene. 2013;32(6):724–735. doi:10.1038/onc.2012.9322430214
   PubMed Web of Science ®Google Scholar
• Lu W, Fu Z, Wang H, Feng J, Wei J, Guo J. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells’ survival by protecting cells from oxidative stress. Mol Cell Biochem. 2014;387(1–2):261–270. doi:10.1007/s11010-013-1891-424234423
   PubMed Web of Science ®Google Scholar
• Yim MB, Chae HZ, Rhee SG, Chock PB, Stadtman ER. On the protective mechanism of the thiol-specific antioxidant enzyme against the oxidative damage of biomacromolecules. J Biol Chem. 1994;269(3):1621–1626. 8294408
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura T, Cho D-H, Gu Z, Lipton SA. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson’s disease. Proc Natl Acad Sci U S A. 2007;104(47):18742–18747. doi:10.1073/pnas.070590410418003920
   PubMed Web of Science ®Google Scholar
• Immenschuh S, Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal. 2005;7(5–6):768–777. doi:10.1089/ars.2005.7.76815890023
   PubMed Web of Science ®Google Scholar
• Kim H, Lee TH, Park ES, et al. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem. 2000;275(24):18266–18270. doi:10.1074/jbc.275.24.1826610849441
   PubMed Web of Science ®Google Scholar
• Kontostathi G, Zoidakis J, Makridakis M, et al. Cervical cancer cell line secretome highlights the roles of transforming growth factor-beta-induced protein Ig-h3, peroxiredoxin-2, and NRF2 on cervical carcinogenesis. Biomed Res Int. 2017;2017:1–15. doi:10.1155/2017/4180703
   Web of Science ®Google Scholar
• Zhang S, Fu Z, Wei J, Guo J, Liu M, Du K. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer. Med Oncol. 2015;32(1):414. 25471788
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang S, Wang R, Wu X, Zeng L, Fu Z. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway. Biosci Rep. 2017;37(3):BSR20160447.
   Web of Science ®Google Scholar
• Perrais D, Merrifield CJ. Dynamics of endocytic vesicle creation. Dev Cell. 2005;9(5):581–592. doi:10.1016/j.devcel.2005.10.00216256734
   PubMed Web of Science ®Google Scholar
• Ochoa GC, Slepnev VI, Neff L, et al. A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol. 2000;150(2):377–389. doi:10.1083/jcb.150.2.37710908579
   PubMed Web of Science ®Google Scholar
• Inokawa Y, Nomoto S, Hishida M, et al. Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis. Onco Targets Ther. 2013;6:1417–1424. doi:10.2147/OTT.S5191324143113
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen C, Guo W, Zheng S, Sun Z, Geng X. DNM3 attenuates hepatocellular carcinoma growth by activating P53. Med Sci Monit. 2016;22:197–205. 26784388
   PubMed Web of Science ®Google Scholar
• Jiang L, Lang Q-L, Liang W-M, et al. Construction of a recombinant eukaryotic expression vector containing DNM3 gene and its expression in colon cancer cells. Onco Targets Ther. 2018;11:6665–6671. doi:10.2147/OTT.S17638830349300
   PubMed Web of Science ®Google Scholar
• Lee Y-Y, Do I-G, Park YA, et al. Low dynamin 2 expression is associated with tumor invasion and metastasis in invasive squamous cell carcinoma of cervix. Cancer Biol Ther. 2010;10(4):329–335. doi:10.4161/cbt.10.4.1227520574164
   PubMed Web of Science ®Google Scholar
• Thaper D, Vahid S, Nip KM, et al. Targeting lyn regulates snail family shuttling and inhibits metastasis. Oncogene. 2017;36(28):3964–3975. doi:10.1038/onc.2017.528288135
   PubMed Web of Science ®Google Scholar
• Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 2014;46(6):372–383. doi:10.3109/07853890.2014.91283624897931
   PubMed Web of Science ®Google Scholar
• Wang R, Wei J, Zhang S, et al. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer. Oncotarget. 2016;7(52):86816–86828. doi:10.18632/oncotarget.1355927894099
   PubMedGoogle Scholar
• Lu W, Fu Z, Wang H, Feng J, Wei J, Guo J. Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/beta-catenin signaling (vol 343, pg 190, 2014). Cancer Lett. 2014;350(1–2):69–69. doi:10.1016/j.canlet.2014.02.020
   Web of Science ®Google Scholar
• Zhang H-J, Yuan G-L, Liang Q-L, et al. Progress of dynamin 3 in tumors. Int J Clin Exp Med. 2017;10(11):15060–15063.
   Web of Science ®Google Scholar
• Li Y, Zhang D, Yu K, et al. CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest. Biol Res. 2018;51:11. 29661232
   PubMed Web of Science ®Google Scholar
• Green DR, Llambi F. Cell death signaling. Cold Spring Harb Perspect Biol. 2015;7(12):a006080. doi:10.1101/cshperspect.a00608026626938
   PubMed Web of Science ®Google Scholar